Nexalin Technology NXL
NASDAQ NXL
$4.21 -0.14 (-3.22%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Operating Margin (2021 - 2026)

Updated

Nexalin Technology (NXL) posted Operating Margin of -18479.69% for Q2 2026, down 16183.47 percentage points from -2296.22% a year earlier and down 4299.74 percentage points from the prior quarter.

Analysis

Nexalin Technology (NXL) Operating Margin (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Margin at Nexalin Technology was -4202.54%, up 954.97 percentage points year-over-year; for FY2025, it came in at -2781.69%, up 1814.45 percentage points from FY2024.

  • Annual Operating Margin shows a four-year change of +1396.01 percentage points (FY2021 to FY2025).
  • In prior years, Nexalin Technology's Operating Margin was -4596.14% in FY2024 (+547.34 pp), -5143.48% in FY2023 (-5004.75 pp), -138.72% in FY2022 (+4038.97 pp) and -4177.70% in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Operating Margin in data going back to Q3 2021.
  • On a year-over-year basis, Operating Margin increased in three of the last eight quarters, with an average year-over-year change of -2857.83 percentage points.
  • The strongest year-over-year quarter for Operating Margin in the past five years was Q4 2025, with a gain of 9175.62 percentage points; the weakest was Q2 2026, with a drop of 16183.47 percentage points.
  • According to Business Quant data, Operating Margin for the three prior quarters was -14179.95% (Q1 2026), -1403.86% (Q4 2025) and -12924.30% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 13.44%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 33.60%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 18.08%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 25.18%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 13.31%
10 Nexalin Technology 3.09 Mn -8.70 Mn 8,897.00 -18,479.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18,479.69%
Mar 31, 2026 -14,179.95%
Dec 31, 2025 -1,403.86%
Sep 30, 2025 -12,924.30%
Jun 30, 2025 -2,296.22%
Mar 31, 2025 -4,903.63%
Dec 31, 2024 -10,579.48%
Sep 30, 2024 -6,962.11%
Jun 30, 2024 -4,832.42%
Mar 31, 2024 -1,364.81%
Dec 31, 2023 -7,910.37%
Sep 30, 2023 -10,017.57%
Jun 30, 2023 -2,467.25%
Mar 31, 2023 -2,550.48%
Dec 31, 2022 -1,872.83%
Sep 30, 2022 -53.77%
Jun 30, 2022 -107.44%
Mar 31, 2022 -116.02%
Dec 31, 2021 -2,406.30%
Sep 30, 2021 -3,207.88%
API Access

Nexalin Technology Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=NXL&period=max&api_key=YOUR_API_KEY